Department of Biostatistics; Department of Medicine, Division of Community Internal Medicine; Department of Medicine, Division of Endocrinology and Metabolism
Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Nutritional and Metabolic Diseases
OBJECTIVE: The American Diabetes Association and the Society of Critical Care Medicine recommend monitoring blood glucose (BG) every 1-2 hours in patients receiving insulin infusion to guide titration of insulin infusion to maintain serum glucose in the target range; however, this is based on weak evidence. We evaluated the compliance of hourly BG monitoring and relation of less frequent BG monitoring to glycemic status.
MATERIALS AND METHODS: Retrospective chart review performed on 56 consecutive adult patients who received intravenous insulin infusion for persistent hyperglycemia in the ICU at Saint Vincent Hospital, a tertiary care community hospital an urban setting in Northeast region of USA. The frequency of fingerstick blood glucose (FSBG) readings was reviewed for compliance with hourly FSBG monitoring per protocol and the impact of FSBG testing at different time intervals on the glycemic status. Depending on time interval of FSBG monitoring, the data was divided into three groups: Group A ( < 90 min), Group B (91-179 min) and Group C ( > /=180 min).
RESULTS: The mean age was 69 years (48% were males), 77% patients had preexisting type 2 diabetes mellitus (T2DM). The mean MPM II score was 41. Of the 1411 readings for BG monitoring on insulin infusion, 467 (33%) were in group A, 806 (57%) in group B and 138 (10%) in group C; hourly BG monitoring compliance was 12.6%. The overall glycemic status was similar among all groups. There were 14 (0.99%) hypoglycemic episodes observed. The rate of hypoglycemic episodes was similar in all three groups (p=0.55).
CONCLUSION: In patients requiring insulin infusion for sustained hyperglycemia in ICU, the risk of hypoglycemic episodes was not significantly different with less frequent BG monitoring. The compliance to hourly blood glucose monitoring and ICU was variable, and hypoglycemic episodes were similar across the groups despite the variation in monitoring.
Hyperglycemia, Critically ill, Insulin Infusion, Hypoglycemia, Blood Glucose
Rights and Permissions
Copyright : © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA. This work is licensed under a Creative Commons Attribution 4.0 International License.
DOI of Published Version
Lal A, Haque N, Lee J, Katta SR, Maranda L, George S, Trivedi N. Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study. Acta Biomed. 2021 Feb 25;92(1):e2021036. doi: 10.23750/abm.v92i1.9083. PMID: 33682835; PMCID: PMC7975947. Link to article on publisher's site
Acta bio-medica : Atenei Parmensis
Lal A, Haque N, Lee J, Katta SR, Maranda L, George S, Trivedi N. (2021). Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study. Open Access Publications by UMMS Authors. https://doi.org/10.23750/abm.v92i1.9083. Retrieved from https://escholarship.umassmed.edu/oapubs/4579
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.